Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma

NCT01712789 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

682

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Pomalidomide
DRUG: Dexamethasone

Sponsor

Celgene